Revenue growth remains inconsistent, evidenced by a 10.3% contraction in 2025Q4, while structural margin pressure persists as SG&A expenses frequently exceed gross profit, such as the $5.1M SG&A against $3.9M gross profit in 2025Q2.
| Sales/Revenue | 18.27M | 18.23M | 17.25M | 13.27M | 14.69M | 10.31M | 12.58M | 11.96M |
| Revenue Growth % | 0.23% | 5.65% | 29.99% | -9.65% | 42.44% | -18% | 5.13% | - |
| Cost of Goods Sold | 10.05M | 11.03M | 9.11M | 7.17M | 7.76M | 5.16M | 5.9M | 6.03M |
| COGS % of Revenue | 55.02% | 60.53% | 52.78% | 54.02% | 52.82% | 50.07% | 46.94% | 50.42% |
| Gross Profit | 8.22M | 7.19M | 8.15M | 6.1M | 6.93M | 5.15M | 6.67M | 5.93M |
| Gross Margin % | 44.98% | 39.47% | 47.22% | 45.98% | 47.18% | 49.93% | 53.06% | 49.58% |
| Gross Profit Growth % | 14.23% | -11.7% | 33.5% | -11.94% | 34.59% | -22.84% | 12.52% | - |
| Operating Expenses | 10.11M | 7.72M | 8.76M | 7.54M | 7.38M | 5.18M | 5.61M | 5.09M |
| OpEx % of Revenue | 55.31% | 42.38% | 50.76% | 56.82% | 50.21% | 50.21% | 44.58% | 42.53% |
| Selling, General & Admin | 10.11M | 7.72M | 8.76M | 7.54M | 7.38M | 5.18M | 5.61M | 5.09M |
| SG&A % of Revenue | 55.31% | 42.38% | 50.76% | 56.82% | 50.21% | 50.21% | 44.58% | 42.53% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.89M | -529.62K | -610.5K | -1.44M | -444.88K | -28.65K | 1.07M | 842.47K |
| Operating Margin % | -10.33% | -2.91% | -3.54% | -10.84% | -3.03% | -0.28% | 8.48% | 7.04% |
| Operating Income Growth % | -256.32% | 13.25% | 57.55% | -223.24% | -1452.99% | -102.68% | 26.65% | - |
| EBITDA | 874.74K | 2.93M | 2.85M | -736.56K | -5.87K | 242.71K | 1.39M | 2.62M |
| EBITDA Margin % | 4.79% | 16.09% | 16.52% | -5.55% | -0.04% | 2.35% | 11.07% | 21.88% |
| EBITDA Growth % | -70.18% | 2.91% | 486.97% | -12454.35% | -102.42% | -82.56% | -46.83% | - |
| D&A (Non-Cash Add-back) | 2.76M | 3.46M | 3.46M | 701.46K | 439.02K | 271.36K | 325.05K | 1.78M |
| EBIT | -1.89M | 881.82K | -610.5K | -1.78M | 96.3K | -5.88K | 1.07M | 842.47K |
| Net Interest Income | 1.28M | 673.02K | 570.08K | -35.46K | -98.03K | -108.85K | -148.9K | -110.01K |
| Interest Income | 1.47M | 723.95K | 570.08K | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 188.33K | 50.93K | 0 | 35.46K | 98.03K | 108.85K | 148.9K | 110.01K |
| Other Income/Expense | 2.15M | 1.36M | 763.5K | 159.37K | 967.93K | -120.8K | -61.81K | -25.34K |
| Pretax Income | 261.69K | 830.89K | 153K | -1.28M | 523.05K | -149.44K | 1.01M | 817.12K |
| Pretax Margin % | 1.43% | 4.56% | 0.89% | -9.63% | 3.56% | -1.45% | 7.99% | 6.83% |
| Income Tax | 74.16K | 74.6K | 119.42K | 9.55K | 16.28K | 14.58K | 59.69K | 58.15K |
| Effective Tax Rate % | 28.34% | 8.98% | 78.05% | -0.75% | 3.11% | -9.76% | 5.94% | 7.12% |
| Net Income | 187.54K | 756.28K | 33.59K | -1.29M | 506.77K | -164.03K | 945.47K | 758.97K |
| Net Margin % | 1.03% | 4.15% | 0.19% | -9.71% | 3.45% | -1.59% | 7.52% | 6.34% |
| Net Income Growth % | -75.2% | 2151.65% | 102.61% | -354.2% | 408.95% | -117.35% | 24.57% | - |
| Net Income (Continuing) | 187.54K | 756.28K | 33.59K | -1.29M | 506.77K | -164.03K | 945.47K | 758.97K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.48 | 3.68 | 0.22 | -8.08 | 3.18 | -1.03 | 5.93 | 4.76 |
| EPS Growth % | -86.96% | 1572.73% | 102.72% | -354.09% | 408.74% | -117.37% | 24.58% | - |
| EPS (Basic) | 0.48 | 3.68 | 0.22 | -8.08 | 3.18 | -1.03 | 5.93 | 4.76 |
| Diluted Shares Outstanding | 389.79K | 205.29K | 155.32K | 159.38K | 159.38K | 159.38K | 159.38K | 159.38K |
| Basic Shares Outstanding | 389.79K | 205.29K | 155.32K | 159.38K | 159.38K | 159.38K | 159.38K | 159.38K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
Geographic concentration and scalability
According to historical income statement data, CHSN's revenue growth has exhibited significant volatility, with a 10.3% contraction in 2025Q4 following a 26.6% expansion in 2024Q4, suggesting that the company's top-line performance remains highly sensitive to seasonal demand and regional market fluctuations in its core Xinjiang operations.
The erratic revenue trajectory indicates that the company has yet to establish a reliable organic growth engine, likely hampered by the dual-market strategy. Investors should monitor whether the recent contraction reflects a saturation of the Xinjiang market or temporary disruptions in the NYC expansion efforts.
Based on reported financial figures, CHSN maintains a gross margin hovering around 45%, yet the company consistently struggles to convert this into operating profitability, as evidenced by the negative operating margins recorded in seven of the last ten quarters analyzed in the provided data.
This persistent gap between gross and operating margins suggests that the company's fixed-cost base, particularly retail lease obligations and administrative overhead, is currently too heavy for its current revenue scale. The inability to achieve consistent operating leverage implies that the artisanal production model may be inherently difficult to scale profitably.
As reported in recent filings, CHSN achieved a 12.9% net margin in 2025Q4 despite a negative operating margin of 7.3%, which indicates that the bottom-line performance is being significantly influenced by non-operating items rather than core operational efficiency or sustainable business growth.
The divergence between operating losses and net income warrants further investigation into the nature of these non-operating gains. Relying on non-core items to achieve profitability may mask underlying operational weaknesses and complicates the assessment of the company's true earnings power.
Analysis of the company's cost structure reveals that SG&A expenses frequently track closely with or exceed gross profit, as seen in 2025Q2 where SG&A of $5.1M eclipsed the $3.9M gross profit, highlighting a lack of expense discipline relative to the company's current revenue throughput.
The high fixed-cost nature of the retail footprint appears to be a primary drag on profitability, particularly as the company attempts to balance its Xinjiang operations with NYC expansion. Without a meaningful reduction in overhead or a significant increase in store-level productivity, the current cost structure may continue to constrain bottom-line results.
Quick answers to the most common questions about buying CHSN stock.
For fiscal year 2025, Chanson International Holding (CHSN) reported total revenue of $18.3M. This represents a 52.7% increase compared to $12.0M in 2018.
Chanson International Holding (CHSN) is profitable, generating $0.2M in net income for the fiscal year ending 2025 with a net profit margin of 1.0%.
Chanson International Holding (CHSN) reported an operating income of $-1.9M, resulting in an operating profit margin of -10.3%. This margin reflects the operational efficiency of the business before interest and taxes.
Chanson International Holding (CHSN) generated $8.2M in gross profit for the year, representing a gross profit margin of 45.0%. This demonstrates the company's core pricing power and production efficiency.